Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma
Clinical trial NCT03662841 · TERMINATED
Trial details
- NCT number
- NCT03662841
- Sponsor
- Chinese University of Hong Kong
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2023-04-17
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.